Transform Wealth, LLC Gilead Sciences, Inc. Transaction History

Transform Wealth, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $463,186 - $580,422	-7,997 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $57,548 - $65,318	-887 Reduced 9.98%	7,997 $581,000
Q3 2021 Oct 15, 2021	SELL	$67.69 - $73.03 $58,890 - $63,536	-870 Reduced 8.92%	8,884 $621,000
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $62,200 - $67,963	-980 Reduced 9.13%	9,754 $672,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $14,820 - $16,909	-247 Reduced 2.25%	10,734 $694,000
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $254,641 - $290,152	-4,495 Reduced 29.04%	10,981 $640,000
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $3.7 Million - $4.65 Million	-59,505 Reduced 79.36%	15,476 $978,000
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $205,951 - $239,148	2,847 Added 3.95%	74,981 $5.77 Million
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $3.82 Million - $4.89 Million	61,017 Added 548.86%	72,134 $5.39 Million
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $95,018 - $104,516	1,542 Added 16.1%	11,117 $722,000
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $518,645 - $572,493	-8,297 Reduced 46.42%	9,575 $607,000
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $1.11 Million - $1.24 Million	17,872 New	17,872 $1.21 Million

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Transform Wealth, LLC with notifications on news.